Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $1.6 Million - $1.84 Million
-6,871 Reduced 42.98%
9,115 $2.22 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $4.07 Million - $4.53 Million
15,986 New
15,986 $4.13 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $25,515 - $132,115
500 Added 22.22%
2,750 $613,000
Q2 2022

Aug 15, 2022

BUY
$234.74 - $275.42 $528,165 - $619,695
2,250 New
2,250 $555,000
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $489,225 - $697,525
-2,500 Closed
0 $0
Q4 2019

Jan 14, 2020

BUY
$236.45 - $266.82 $59,112 - $66,705
250 Added 11.11%
2,500 $680,000
Q3 2019

Nov 04, 2019

BUY
$230.58 - $256.08 $518,805 - $576,180
2,250 New
2,250 $569,000
Q1 2019

May 06, 2019

SELL
$206.05 - $248.17 $4,327 - $5,211
-21 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$233.07 - $256.0 $4,894 - $5,376
21 New
21 $5,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Brasada Capital Management, LP Portfolio

Follow Brasada Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brasada Capital Management, LP with notifications on news.